Cartesian Therapeutics
RNAC
#7001
Rank
C$0.62 B
Marketcap
$24.72
Share price
-5.71%
Change (1 day)
-15.52%
Change (1 year)

Cartesian Therapeutics (RNAC) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$0.65 Billion

According to Cartesian Therapeutics's latest financial reports the company's total liabilities are C$0.65 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cartesian Therapeutics - Total liabilities on balance sheet (from 2015 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$0.98 B910.89%
2022-12-31C$97.77 M-44.15%
2021-12-31C$0.17 B-25.16%
2020-12-31C$0.23 B96.43%
2019-12-31C$0.11 B75.18%
2018-12-31C$67.97 M9.7%
2017-12-31C$61.96 M34.26%
2016-12-31C$46.15 M-79.12%
2015-12-31C$0.22 B73.16%
2014-12-31C$0.12 B